Robert Dunkle

Bob has more than 25 years’ experience leading business growth in life sciences including therapeutics, diagnostics, gene expression analysis platforms, disease management, informatics, imaging and process monitoring and control. Presently, he is president of A.B.E.S Partners, a management consulting company focusing on corporate strategy, M&A and fundraising for life science and software companies.

He has raised over $35M in venture capital, served as CEO of three life science companies and, as VP/GM at the world’s largest cheminformatics company, helped achieve an IPO followed by a buy-out. As a principal player, he has turned three businesses from perennial losses to sustained profitability. Most recently in his company development business, he has served as COO, CBO and BOD member in numerous companies as well as a mentor or EIR for QB3, Mission Bay Capital, UC (Berkeley, Davis, Santa Cruz, and San Francisco), ASTIA and a member of the advisory board in computer and life sciences at SFSU.

He holds an BS in Chemical Engineering at Drexel University and MBA with an emphasis in Applied Economics from UC Berkeley.